AstraZeneca PLC Files 6-K on Voting Rights
Ticker: AZN · Form: 6-K · Filed: 2026-04-01T10:30:32-04:00
Sentiment: neutral
Topics: disclosure, voting-rights, foreign-issuer
TL;DR
AZN filed a 6-K on voting rights. Standard disclosure.
AI Summary
On April 1, 2026, AstraZeneca PLC filed a Form 6-K with the SEC, reporting its total voting rights and the admission of shares. The filing provides details on the company's mailing and business addresses in Cambridge, United Kingdom, and includes contact information.
Why It Matters
This filing provides essential information regarding AstraZeneca's share structure and voting rights, which is crucial for investors to understand their stake and influence in the company.
Risk Assessment
Risk Level: low — This is a routine disclosure filing that does not contain new financial information or significant operational updates.
Key Players & Entities
- ASTRAZENECA PLC (company) — Filer
- 0000901832 (company) — CIK
- 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE United Kingdom CB2 0AA (location) — Mailing and Business Address
- 011 44 20 7304 5000 (phone) — Contact Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign issuer required by the SEC, used to submit information that the company has made or is required to make public in its home country.
When was this specific Form 6-K filed and accepted by the SEC?
This Form 6-K was filed and accepted on April 1, 2026.
What is AstraZeneca PLC's CIK number?
AstraZeneca PLC's CIK number is 0000901832.
Where are AstraZeneca PLC's primary business and mailing addresses located?
AstraZeneca PLC's primary business and mailing addresses are located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA.
What is the SIC code for AstraZeneca PLC?
The SIC code for AstraZeneca PLC is 2834, which corresponds to Pharmaceutical Preparations.
From the Filing
EDGAR Filing Documents for 0001654954-26-003157 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: SEC Accession No. 0001654954-26-003157 Filing Date 2026-04-01 Accepted 2026-04-01 10:30:32 Documents 1 Period of Report 2026-04-01 Document Format Files Seq Description Document Type Size 1 TOTAL VOTING RIGHTS AND ADMISSION OF SHARES a9429y.htm 6-K 40994 Complete submission text file 0001654954-26-003157.txt 42290 Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE United Kingdom CB2 0AA Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE United Kingdom CB2 0AA 011 44 20 7304 5000 ASTRAZENECA PLC (Filer) CIK : 0000901832 (see all company filings) EIN. : 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231 Type: 6-K | Act: 34 | File No.: 001-11960 | Film No.: 26825447 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)